---
pmid: '33799212'
title: 'A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding
  the spectrum of phosphorylase kinase b (PhK) deficiency.'
authors:
- Bisciglia M
- Froissart R
- Bedat-Millet AL
- Romero NB
- Pettazzoni M
- Hogrel JY
- Petit FM
- Stojkovic T
journal: J Neurol Sci
year: '2021'
full_text_available: false
doi: 10.1016/j.jns.2021.117391
---

# A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding the spectrum of phosphorylase kinase b (PhK) deficiency.
**Authors:** Bisciglia M, Froissart R, Bedat-Millet AL, Romero NB, Pettazzoni M, Hogrel JY, Petit FM, Stojkovic T
**Journal:** J Neurol Sci (2021)
**DOI:** [10.1016/j.jns.2021.117391](https://doi.org/10.1016/j.jns.2021.117391)

## Abstract

1. J Neurol Sci. 2021 May 15;424:117391. doi: 10.1016/j.jns.2021.117391. Epub
2021  Mar 18.

A novel PHKA1 mutation associating myopathy and cognitive impairment: Expanding 
the spectrum of phosphorylase kinase b (PhK) deficiency.

Bisciglia M(1), Froissart R(2), Bedat-Millet AL(3), Romero NB(4), Pettazzoni 
M(5), Hogrel JY(6), Petit FM(7), Stojkovic T(8).

Author information:
(1)Centre de Référence Neuromusculaire Erasme-HUDERF, Service de Neurologie, 
Cliniques Universitaires de Bruxelles, Hôpital Erasme, Université Libre de 
Bruxelles (ULB), Route de Lennik 808, 1070 Bruxelles, Belgique.. Electronic 
address: michela.bisciglia@erasme.ulb.ac.be.
(2)Biochemical and Molecular Biology Department, Centre de Biologie et de 
Pathologie Est, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: 
roseline.froissart@chu-lyon.fr.
(3)Service de Neurologie, Centre Hospitalier de Rouen, Hôpital Charles Nicolle, 
76038 Rouen, France. Electronic address: Anne-Laure.Bedat-Millet@chu-rouen.fr.
(4)APHP-GH Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires 
Nord/Est/Ile de France, Myology Institute, Paris, France; APHP-GH 
Pitié-Salpêtrière, Unité de Morphologie Neuromusculaire « Risler », Myology 
Institute, Sorbonne Université, INSERM, Hôpital Pitié-Salpêtrière, Paris, 
France. Electronic address: nb.romero@institut-myologie.org.
(5)Biochemical and Molecular Biology Department, Centre de Biologie et de 
Pathologie Est, Hospices Civils de Lyon, 69500 Bron, France. Electronic address: 
magali.pettazzoni@chu-lyon.fr.
(6)APHP-GH Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires 
Nord/Est/Ile de France, Myology Institute, Paris, France. Electronic address: 
jy.hogrel@institut-myologie.org.
(7)AP-HP. Université Paris Saclay, Laboratoire de génétique moléculaire, Hôpital 
Antoine Béclère, Clamart, France. Electronic address: francois.petit2@aphp.fr.
(8)APHP-GH Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires 
Nord/Est/Ile de France, Myology Institute, Paris, France. Electronic address: 
tanya.stojkovic@aphp.fr.

Muscle phosphorylase kinase b deficiency (PhK) is a rare disorder of glycogen 
metabolism characterized by exercise-induced myalgia and cramps, myoglobinuria 
and progressive muscle weakness. PhK deficiency is due to mutations in the PHKA1 
gene inherited in an X-linked manner and is associated to glycogenosis type VIII 
(GSD VIII also called GSD IXd). PHKA1 gene codes for the αM subunit of the PhK, 
a multimeric protein complex responsible for the control of glycogen breakdown 
in muscle. Until now, few patients have been reported with X-linked recessive 
muscle PhK deficiency due to PHKA1 mutations. All reported patients presented 
with exercise intolerance and mild myopathy and one of them had cognitive 
impairment, leading to speculate about a central nervous system involvement in 
GSD VIII. Here we report in a sibling a novel mutation in the PHKA1 gene 
associated with a progressive myopathy, exercise intolerance, muscle hypertrophy 
and cognitive impairment as an associated feature. This report expands the 
genetic and clinical spectrum of the extremely rare PHKA1-related PhK deficiency 
and presents new evidences about its involvement in brain development.

Copyright © 2021 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.jns.2021.117391
PMID: 33799212 [Indexed for MEDLINE]
